vs
Enact Holdings, Inc.（ACT）与NEOGENOMICS INC（NEO）财务数据对比。点击上方公司名可切换其他公司
Enact Holdings, Inc.的季度营收约是NEOGENOMICS INC的1.7倍（$312.1M vs $186.7M），Enact Holdings, Inc.净利率更高（53.8% vs -57.9%，领先111.7%），NEOGENOMICS INC同比增速更快（11.1% vs 1.7%），过去两年NEOGENOMICS INC的营收复合增速更高（6.5% vs 2.2%）
Enact Holdings, Inc.是美国领先的私人抵押贷款保险服务商，为银行、信用社等各类住宅抵押贷款机构提供风险缓释解决方案，帮助首付较低的购房者获得可负担的住房贷款，助力更多美国普通消费者实现安居需求。
新基因组公司（NeoGenomics）是美国一家经CLIA认证的临床实验室企业，提供药企服务与信息服务，专注于癌症基因诊断检测，旗下检测服务涵盖细胞遗传学、荧光原位杂交（FISH）、流式细胞术、免疫组化、解剖病理学及分子遗传学等多个领域，为肿瘤相关诊断提供专业支持。
ACT vs NEO — 直观对比
营收规模更大
ACT
是对方的1.7倍
$186.7M
营收增速更快
NEO
高出9.4%
1.7%
净利率更高
ACT
高出111.7%
-57.9%
两年增速更快
NEO
近两年复合增速
2.2%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $312.1M | $186.7M |
| 净利润 | $168.0M | $-108.0M |
| 毛利率 | — | 43.3% |
| 营业利润率 | — | 46.9% |
| 净利率 | 53.8% | -57.9% |
| 营收同比 | 1.7% | 11.1% |
| 净利润同比 | 1.2% | 42.0% |
| 每股收益（稀释后） | $1.18 | $-0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACTNEO
| Q1 26 | $312.1M | $186.7M | ||
| Q4 25 | $312.7M | $190.2M | ||
| Q3 25 | $311.5M | $187.8M | ||
| Q2 25 | $304.9M | $181.3M | ||
| Q1 25 | $306.8M | $168.0M | ||
| Q4 24 | $301.8M | $172.0M | ||
| Q3 24 | $309.6M | $167.8M | ||
| Q2 24 | $298.8M | $164.5M |
净利润ACTNEO
| Q1 26 | $168.0M | $-108.0M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $-27.1M | ||
| Q2 25 | — | $-45.1M | ||
| Q1 25 | — | $-25.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-17.7M | ||
| Q2 24 | — | $-18.6M |
毛利率ACTNEO
| Q1 26 | — | 43.3% | ||
| Q4 25 | — | 43.8% | ||
| Q3 25 | — | 42.8% | ||
| Q2 25 | — | 42.6% | ||
| Q1 25 | — | 43.6% | ||
| Q4 24 | — | 44.9% | ||
| Q3 24 | — | 44.6% | ||
| Q2 24 | — | 44.1% |
营业利润率ACTNEO
| Q1 26 | — | 46.9% | ||
| Q4 25 | 71.3% | -7.1% | ||
| Q3 25 | 67.4% | -14.4% | ||
| Q2 25 | 70.4% | -26.3% | ||
| Q1 25 | 68.9% | -16.6% | ||
| Q4 24 | 68.9% | -10.7% | ||
| Q3 24 | 74.1% | -12.6% | ||
| Q2 24 | 78.6% | -13.3% |
净利率ACTNEO
| Q1 26 | 53.8% | -57.9% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | -14.4% | ||
| Q2 25 | — | -24.9% | ||
| Q1 25 | — | -15.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -10.5% | ||
| Q2 24 | — | -11.3% |
每股收益（稀释后）ACTNEO
| Q1 26 | $1.18 | $-0.13 | ||
| Q4 25 | $1.23 | — | ||
| Q3 25 | $1.10 | — | ||
| Q2 25 | $1.11 | — | ||
| Q1 25 | $1.08 | — | ||
| Q4 24 | $1.05 | — | ||
| Q3 24 | $1.15 | — | ||
| Q2 24 | $1.16 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $549.0M | $146.1M |
| 总债务越低越好 | $744.9M | — |
| 股东权益账面价值 | $5.3B | $828.8M |
| 总资产 | $7.0B | $1.3B |
| 负债/权益比越低杠杆越低 | 0.14× | — |
8季度趋势，按日历期对齐
现金及短期投资ACTNEO
| Q1 26 | $549.0M | $146.1M | ||
| Q4 25 | $582.5M | $159.6M | ||
| Q3 25 | $545.6M | $164.1M | ||
| Q2 25 | $616.0M | $154.7M | ||
| Q1 25 | $639.0M | $346.2M | ||
| Q4 24 | $602.8M | $367.0M | ||
| Q3 24 | $674.9M | $362.0M | ||
| Q2 24 | $711.3M | $355.1M |
总债务ACTNEO
| Q1 26 | $744.9M | — | ||
| Q4 25 | $744.5M | $341.9M | ||
| Q3 25 | $744.1M | — | ||
| Q2 25 | $743.8M | — | ||
| Q1 25 | $743.4M | — | ||
| Q4 24 | $743.0M | $541.1M | ||
| Q3 24 | $742.7M | — | ||
| Q2 24 | $742.4M | — |
股东权益ACTNEO
| Q1 26 | $5.3B | $828.8M | ||
| Q4 25 | $5.4B | $836.6M | ||
| Q3 25 | $5.3B | $838.3M | ||
| Q2 25 | $5.2B | $854.0M | ||
| Q1 25 | $5.1B | $888.3M | ||
| Q4 24 | $5.0B | $902.3M | ||
| Q3 24 | $5.0B | $908.2M | ||
| Q2 24 | $4.8B | $915.9M |
总资产ACTNEO
| Q1 26 | $7.0B | $1.3B | ||
| Q4 25 | $6.9B | $1.4B | ||
| Q3 25 | $6.9B | $1.4B | ||
| Q2 25 | $6.8B | $1.4B | ||
| Q1 25 | $6.7B | $1.6B | ||
| Q4 24 | $6.5B | $1.6B | ||
| Q3 24 | $6.6B | $1.6B | ||
| Q2 24 | $6.3B | $1.6B |
负债/权益比ACTNEO
| Q1 26 | 0.14× | — | ||
| Q4 25 | 0.14× | 0.41× | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.14× | — | ||
| Q1 25 | 0.15× | — | ||
| Q4 24 | 0.15× | 0.60× | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | 0.15× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-8.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ACTNEO
| Q1 26 | — | $-8.1M | ||
| Q4 25 | $724.5M | $1.3M | ||
| Q3 25 | $192.0M | $8.9M | ||
| Q2 25 | $119.5M | $20.3M | ||
| Q1 25 | $226.7M | $-25.3M | ||
| Q4 24 | $686.3M | $9.8M | ||
| Q3 24 | $188.1M | $9.2M | ||
| Q2 24 | $144.7M | $13.9M |
自由现金流ACTNEO
| Q1 26 | — | — | ||
| Q4 25 | — | $-6.5M | ||
| Q3 25 | — | $570.0K | ||
| Q2 25 | — | $14.0M | ||
| Q1 25 | — | $-29.8M | ||
| Q4 24 | — | $-1.8M | ||
| Q3 24 | — | $-1.6M | ||
| Q2 24 | — | $814.0K |
自由现金流率ACTNEO
| Q1 26 | — | — | ||
| Q4 25 | — | -3.4% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 7.7% | ||
| Q1 25 | — | -17.8% | ||
| Q4 24 | — | -1.0% | ||
| Q3 24 | — | -0.9% | ||
| Q2 24 | — | 0.5% |
资本支出强度ACTNEO
| Q1 26 | — | — | ||
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 4.4% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.7% | ||
| Q4 24 | — | 6.7% | ||
| Q3 24 | — | 6.4% | ||
| Q2 24 | — | 8.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACT
| Premiums | $242.8M | 78% |
| Other | $69.2M | 22% |
NEO
暂无分部数据
